It has been confirmed in studies that FEZF1‐AS1 can regulate the tumor progression by interacting with different miRNAs such as miR‐196a, miR‐107, and miR‐30a in cancers like oral squamous cell carcinoma (OSCC), pancreatic duct adenocarcinoma (PDAC), and breast cancer (Xu et al., 2019; Ye et al., 2018; Zhang et al., 2018). The gene discussed is FEZF1; the disease is pancreatic ductal adenocarcinoma.